sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has released its Form 8.3, detailing its dealings in Mural Oncology plc. As per the disclosure, Vanguard holds 771,443 ordinary shares, representing a 4.47% interest in Mural Oncology. The position disclosure date is August 29, 2025.
The filing follows the rules set by the Irish Takeover Panel Act, 1997 and the Takeover Rules, 2022. The document reveals that no other positions, cash-settled, or stock-settled derivatives currently exist regarding Mural Oncology. Furthermore, Vanguard reported a minor transaction involving the sale of 16 ordinary shares at $2.06 each.
There are no indemnity arrangements or agreements relating to options or derivatives. The disclosure also confirms no additional Supplemental Form 8 is attached.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.